Remove Healthcare Provider Remove Patients Remove Prescription Remove Transportation
article thumbnail

Access solutions: the missing link that prevents biopharma innovation from reaching patients

pharmaphorum

Science has taken a vertical growth trajectory, yet such innovations are, at best, slow to reach the patients in need. We believe that innovation in patient access models is the necessary catalyst to aid patients in starting on and staying on the therapies they need to improve their lives.

article thumbnail

Clarify Health Launches Real-World Evidence on Health Disparities

Clarify Health

Clarify Health launched new applications of its anonymized patient-level social determinants of health (SDoH) insights to help life sciences companies on their patient-first missions. Clarify has access to vast sources of clinically relevant consumer data for all Americans. Read the full press release here.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Trending Technologies in Healthcare

Referral MD

These new technologies can help improve patients’ lives, streamline operations, and save money for hospitals. Here are six of the hottest recent trends that will be changing healthcare in 2023: 1. AI can help healthcare providers predict outcomes, improve patient care and reduce costs.

article thumbnail

The Vital Role of Caregiver Communications: A Caregiver’s Perspective

PM360

10 As healthcare communicators, we prioritize patients, as we should. Healthcare brands must have intentional programs to communicate information to caregivers effectively, especially for those with health literacy, education, or language barriers.

article thumbnail

Diversity and inclusion in oncology clinical trials

Clarify Health

By enrolling participants with a wide range of baseline characteristics, study populations will more accurately reflect the patients likely to take the drug if it is approved. Cancer patients treated in clinical trials live substantially longer than those not treated in trials and benefit from lower hospital readmissions. 2] Figure 1.

article thumbnail

Nine for 2023, part three: thriving or surviving?

pharmaphorum

For the most commonly used, high volume medicines, countrywide networks of distribution to get them to where patients live, reliably, securely, and regularly, are required. According to Medicines for Europe, medicine transportation costs increased up to 500%, in 2022.

article thumbnail

Readjusting the Life Sciences Industry’s Approach to Improving Adherence

PM360

Addressing the issue of medication adherence begins before a patient even fills their first prescription. According to a recent IQVIA analysis, only one in four patients who were new to a brand in 2021 successfully initiated therapy. “To